Composite Cardiovascular Outcomes in Patients With Primary Aldosteronism Undergoing Medical Versus Surgical Treatment: A Meta-Analysis

BackgroundSuperior outcomes after surgical treatment over medical treatment for primary aldosteronism (PA) has been reported in small-scale clinical studies, but no solid conclusion has been drawn as results of large randomized trials are lacking.MethodsWe performed a search of PubMed, MEDLINE, Emba...

Full description

Bibliographic Details
Main Authors: Wei-Chieh Huang, Ying-Ying Chen, Yen-Hung Lin, Jeff S. Chueh
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-05-01
Series:Frontiers in Endocrinology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2021.644260/full
id doaj-2de75e805e8540f89553f34762c2071a
record_format Article
spelling doaj-2de75e805e8540f89553f34762c2071a2021-05-17T06:22:25ZengFrontiers Media S.A.Frontiers in Endocrinology1664-23922021-05-011210.3389/fendo.2021.644260644260Composite Cardiovascular Outcomes in Patients With Primary Aldosteronism Undergoing Medical Versus Surgical Treatment: A Meta-AnalysisWei-Chieh Huang0Wei-Chieh Huang1Ying-Ying Chen2Ying-Ying Chen3Yen-Hung Lin4Yen-Hung Lin5Jeff S. Chueh6Division of Cardiology, Department of Internal Medicine, Taipei Veterans General Hospital, Taipei, TaiwanSchool of Medicine, National Yang-Ming Chiao-Tung University, Taipei, TaiwanDivision of Nephrology, Department of Internal Medicine, MacKay Memorial Hospital, Taipei, TaiwanGraduate Institute of Clinical Medicine, College of Medicine, National Taiwan University Hospital, Taipei, TaiwanGraduate Institute of Clinical Medicine, College of Medicine, National Taiwan University Hospital, Taipei, TaiwanDepartment of Internal Medicine, National Taiwan University Hospital, Taipei, TaiwanGlickman Urological and Kidney Institute, and Cleveland Clinic Lerner College of Medicine, Cleveland Clinic, Cleveland, OH, United StatesBackgroundSuperior outcomes after surgical treatment over medical treatment for primary aldosteronism (PA) has been reported in small-scale clinical studies, but no solid conclusion has been drawn as results of large randomized trials are lacking.MethodsWe performed a search of PubMed, MEDLINE, Embase and Cochrane Library for randomized or observational studies that investigated cardiovascular outcomes in patients with PA undergoing medical versus surgical treatment. Meta-analyses of both composite and individual outcomes were conducted. Risks of bias of the included studies were assessed with Risk Of Bias In Non-randomized Studies of Interventions (ROBINS-I) checklist. Trial sequential analysis (TSA) was performed to control the risk of random errors and assess whether the results in our meta-analysis were conclusive.ResultsA total of 12 studies, including a total of 6148 PA patients, were included in the meta-analysis. The results of meta-analyses demonstrated lower incidence of composite cardiovascular outcomes among PA patients who underwent surgical treatment over medical treatment (odds ratio (OR): 0.49). Surgical treatment also led to less incidence of persistence of hypertension (OR of non-cure hypertension: 0.31). Fewer major cardiovascular events and mortality events were observed (OR: 0.60) after surgical treatment. TSA result showed that the required information size was 2151 and the cumulative Z curve crossed the futility boundary and reached the required information size.ConclusionSuperior performance of surgical treatment over medical treatment is confirmed with meta-analyses in terms of lower incidences of composite cardiovascular outcomes and non-cure of hypertension. Hence, adrenalectomy could now be concluded as the treatment of choice for lateralized PA.https://www.frontiersin.org/articles/10.3389/fendo.2021.644260/fullprimary aldosteronismadrenalectomymineralocorticoid receptor antagonistssurgical treatmentmedical treatmentROBINS-I
collection DOAJ
language English
format Article
sources DOAJ
author Wei-Chieh Huang
Wei-Chieh Huang
Ying-Ying Chen
Ying-Ying Chen
Yen-Hung Lin
Yen-Hung Lin
Jeff S. Chueh
spellingShingle Wei-Chieh Huang
Wei-Chieh Huang
Ying-Ying Chen
Ying-Ying Chen
Yen-Hung Lin
Yen-Hung Lin
Jeff S. Chueh
Composite Cardiovascular Outcomes in Patients With Primary Aldosteronism Undergoing Medical Versus Surgical Treatment: A Meta-Analysis
Frontiers in Endocrinology
primary aldosteronism
adrenalectomy
mineralocorticoid receptor antagonists
surgical treatment
medical treatment
ROBINS-I
author_facet Wei-Chieh Huang
Wei-Chieh Huang
Ying-Ying Chen
Ying-Ying Chen
Yen-Hung Lin
Yen-Hung Lin
Jeff S. Chueh
author_sort Wei-Chieh Huang
title Composite Cardiovascular Outcomes in Patients With Primary Aldosteronism Undergoing Medical Versus Surgical Treatment: A Meta-Analysis
title_short Composite Cardiovascular Outcomes in Patients With Primary Aldosteronism Undergoing Medical Versus Surgical Treatment: A Meta-Analysis
title_full Composite Cardiovascular Outcomes in Patients With Primary Aldosteronism Undergoing Medical Versus Surgical Treatment: A Meta-Analysis
title_fullStr Composite Cardiovascular Outcomes in Patients With Primary Aldosteronism Undergoing Medical Versus Surgical Treatment: A Meta-Analysis
title_full_unstemmed Composite Cardiovascular Outcomes in Patients With Primary Aldosteronism Undergoing Medical Versus Surgical Treatment: A Meta-Analysis
title_sort composite cardiovascular outcomes in patients with primary aldosteronism undergoing medical versus surgical treatment: a meta-analysis
publisher Frontiers Media S.A.
series Frontiers in Endocrinology
issn 1664-2392
publishDate 2021-05-01
description BackgroundSuperior outcomes after surgical treatment over medical treatment for primary aldosteronism (PA) has been reported in small-scale clinical studies, but no solid conclusion has been drawn as results of large randomized trials are lacking.MethodsWe performed a search of PubMed, MEDLINE, Embase and Cochrane Library for randomized or observational studies that investigated cardiovascular outcomes in patients with PA undergoing medical versus surgical treatment. Meta-analyses of both composite and individual outcomes were conducted. Risks of bias of the included studies were assessed with Risk Of Bias In Non-randomized Studies of Interventions (ROBINS-I) checklist. Trial sequential analysis (TSA) was performed to control the risk of random errors and assess whether the results in our meta-analysis were conclusive.ResultsA total of 12 studies, including a total of 6148 PA patients, were included in the meta-analysis. The results of meta-analyses demonstrated lower incidence of composite cardiovascular outcomes among PA patients who underwent surgical treatment over medical treatment (odds ratio (OR): 0.49). Surgical treatment also led to less incidence of persistence of hypertension (OR of non-cure hypertension: 0.31). Fewer major cardiovascular events and mortality events were observed (OR: 0.60) after surgical treatment. TSA result showed that the required information size was 2151 and the cumulative Z curve crossed the futility boundary and reached the required information size.ConclusionSuperior performance of surgical treatment over medical treatment is confirmed with meta-analyses in terms of lower incidences of composite cardiovascular outcomes and non-cure of hypertension. Hence, adrenalectomy could now be concluded as the treatment of choice for lateralized PA.
topic primary aldosteronism
adrenalectomy
mineralocorticoid receptor antagonists
surgical treatment
medical treatment
ROBINS-I
url https://www.frontiersin.org/articles/10.3389/fendo.2021.644260/full
work_keys_str_mv AT weichiehhuang compositecardiovascularoutcomesinpatientswithprimaryaldosteronismundergoingmedicalversussurgicaltreatmentametaanalysis
AT weichiehhuang compositecardiovascularoutcomesinpatientswithprimaryaldosteronismundergoingmedicalversussurgicaltreatmentametaanalysis
AT yingyingchen compositecardiovascularoutcomesinpatientswithprimaryaldosteronismundergoingmedicalversussurgicaltreatmentametaanalysis
AT yingyingchen compositecardiovascularoutcomesinpatientswithprimaryaldosteronismundergoingmedicalversussurgicaltreatmentametaanalysis
AT yenhunglin compositecardiovascularoutcomesinpatientswithprimaryaldosteronismundergoingmedicalversussurgicaltreatmentametaanalysis
AT yenhunglin compositecardiovascularoutcomesinpatientswithprimaryaldosteronismundergoingmedicalversussurgicaltreatmentametaanalysis
AT jeffschueh compositecardiovascularoutcomesinpatientswithprimaryaldosteronismundergoingmedicalversussurgicaltreatmentametaanalysis
_version_ 1721438629675401216